Released by Bio-Modeling Systems : The Predictive Integrative Biology Company

BIO-MODELING SYSTEMS TO THE FOREFRONT OF BIOLOGICAL PROFILING AND MODELLING IN THE USA                                                                         

Paris, France,  July  18,  2005 - We have the pleasure to announce that our Founder and CSO, Dr. François Iris, is invited as plenary speaker, to the CHI’s (Cambridge Healthtech Institute’s) conference on “Analytical Methods for Metabolic Profiling: Solving Problems Analysis" in Orlando Florida on December 9, 2005. He will speak about  “Integrative Analysis of Complex Physiological Networks”. 
If available, we invite you to come to his presentation and have a talk with him during this meeting to discover and/or discuss the operational outputs of our Predictive Integrative Biology CADI™ process.

If you cannot meet us in Orlando, we invite you to download our new presentation, our latest models publications and the CHI’s conference program from our website: www.bmsystems.net

About the Company:
Our company elaborates immediately exploitable comprehensive predictive biological models directly leading to significant improvements in the success-rate of drug development. 

We have repeatedly demonstrated, in a wide variety of therapeutic domains (from cancers to neurological and immunological disorders), our unique ability to successfully carry-out this highly specialised task and to achieve and deliver the expected end results: 

•	We find and validate new therapeutic/pathological/side effects mechanisms;
•	We find and validate the mechanisms of action for novel small molecules, 
•	We find and validate new therapies from client's existing drug and target portfolios.

Constructing accurate and directly exploitable predictive biological models of complex pathologies is NOT a matter of computational technologies. It is a matter of biological expertise assisted by efficient information systems.

Bio-Modeling Systems is the only independent Predictive Integrative Biology company that:

•	Has already produced ten semi-quantitative in-silico integrated physiological models of complex human pathologies.
•	Has independently experimentally tested four of them and validated all four .
•	Has already published two in peer reviewed scientific journals: Nucleic Acids Research  and the Journal of Molecular Endocrinology.
•	Is preparing publication of another two.
•	Accepts to be paid on results and to share business risks with its clients, and
•	Is currently contractually collaborating with Big Pharma in major domains of drugs and targets therapeutic applications.

Looking forward meeting you in the near future,

Best regards,

Manuel GEA 
Co-founder and CEO
BIO-MODELING SYSTEMS
Predictive Integrative Biology
26 rue Saint Lambert
75015 PARIS FRANCE
mobile: +33 (0)6 83 06 12 72
email: manuel.gea@bmsystems.net
web: www.bmsystems.net